CHICAGO--(BUSINESS WIRE)--
Cresco
Labs (CSE:CL) (OTC:CRLBF) (“Cresco” or “the Company”), one of the
largest vertically integrated multistate cannabis operators in the
United States, today announced the opening of the Hope Heal Health
Dispensary (HHH) in Fall River, Bristol County, Massachusetts. Cresco
Labs entered in to a definitive merger agreement with HHH for its
Massachusetts cultivation, manufacturing, processing, and dispensary
operations at the end of 2018. The merger is pending state regulatory
approval.
“With another fast-to-market example of our successful execution, we are
pleased to offer relief and comfort to 60,000 certified patients in
Massachusetts,” said Charles Bachtell, CEO and cofounder of Cresco Labs.
“Massachusetts is a robust and fast growth cannabis market, and HHH
expects its first pilot harvest from its Fall River cultivation facility
towards the end of the first quarter. Cresco has applied for adult use
licensing for our Fall River dispensary, which opened today with a
selection of medical-grade cannabis vape cartridges, edibles, tinctures,
topicals, concentrates, and flower from three Massachusetts cultivators.”
Patients can purchase up to 10 ounces every two months after being
certified by a physician for any one of the Massachusetts state-approved
debilitating medical conditions. Cresco Labs’ core mission of patient
education and outreach will help inform patients about using medical
cannabis as medicine through private one-on-one consultations.
HHH has licensing that allows for cultivation, manufacturing, processing
and the establishment and operation of a medical cannabis dispensary,
with the ability to obtain up to two additional medical cannabis
dispensary licenses and three adult-use dispensary licenses.
The Hope Heal Health Dispensary, located at 1 West Street in Fall River,
MA, is open daily, 10:00 am to 7:00 pm. For more information call
774-377-9333.
About Cresco Labs:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with
experienced management, access to capital and a demonstrated growth
strategy. As a differentiated grower, processor and retailer of premium
cannabis operating in seven states, the company focuses on entering
highly regulated markets with outsized demand potential and high
barriers to entry. Its impressive speed-to-market gives Cresco a
distinct competitive advantage as it replicates its model to expand its
national footprint. Cresco’s proven ability to execute is complemented
by a cutting-edge brand strategy spearheaded by several of the brightest
minds in consumer marketing in the nation. Cresco’s products are
tailored to all major consumer segments: everyday cannabis, medicinally
focused, connoisseur grade, and chef inspired edibles by James Beard
Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the
meaning of applicable Canadian securities legislation and may also
contain statements that may constitute "forward-looking statements"
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only the Company's beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of the Company's control. Generally, such forward-looking
information or forward-looking statements can be identified by the use
of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’
‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’
‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the
negative of those forms or other comparable terms. The Company’s
forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the Company’s actual
results, performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by the
forward-looking statements, including but not limited to those risks
discussed under "Risk Factors" in the company’s CSE Listing Statement
filed with SEDAR; and other factors, many of which are beyond the
control of the Company. Readers are cautioned that the foregoing list of
factors is not exhaustive. Because of these uncertainties, you should
not place undue reliance on the Company’s forward-looking statements. No
assurances are given as to the future trading price or trading volumes
of Cresco’s shares, nor as to the Company’s financial performance in
future financial periods. The Company does not intend to update any of
these factors or to publicly announce the result of any revisions to any
of the Company’s forward-looking statements contained herein, whether as
a result of new information, any future event or otherwise. Except as
otherwise indicated, this press release speaks as of the date hereof.
The distribution of this press release does not imply that there has
been no change in the affairs of the Company after the date hereof or
create any duty or commitment to update or supplement any information
provided in this press release or otherwise.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190220005114/en/
Media:
Jason Erkes, Cresco Labs
Chief Communications
Officer
press@crescolabs.com
Investors:
Aaron
Miles, Cresco Labs
Vice President, Investor Relations
investors@crescolabs.com
For
general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com
Source: Cresco Labs